Skip to main content
. 2018 Apr 13;9(28):19555–19568. doi: 10.18632/oncotarget.24656

Figure 3. Analysis of OSBPL10 mutations and somatic hypermutation target motifs.

Figure 3

(A) Proportion of RGYW/WRCY motif mutations to all somatic mutations. (B) Proportion of CT/GA mutations to all somatic mutations.